United States

People: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

27 Apr 2017
Change (% chg)

$1.44 (+4.61%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Ertel, Steven 

Mr. Steven D. Ertel is Chief Operating Officer, Executive Vice President of Acceleron Pharma Inc. He joined Acceleron in May 2006 and is our Executive Vice President and Chief Medical Officer. Since October 2016, Dr. Sherman has served on the board of directors of Pulmatrix, Inc. Previously, he served as Senior Vice President and Chief Medical Officer at Synta Pharmaceuticals Corp. where he was responsible for clinical research, clinical operations, biostatistics, data management, regulatory affairs, quality assurance and program management. Prior to that, Dr. Sherman worked at Genetics Institute and Wyeth Pharmaceuticals in various capacities including Therapeutic Area Director for Oncology. While at Wyeth, Dr. Sherman provided senior oncology and hematology leadership for worldwide clinical development for both small molecule and biologic therapeutics, including the submission and approval of Mylotarg® by the FDA. He has published numerous papers and book chapters in the field of oncology and clinical development and is named as an inventor of several patents. Dr. Sherman is board certified in Medical Oncology and Internal Medicine and held various clinical positions at Harvard Medical School with corresponding hospital appointments at the Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Sherman received an SB in chemistry from the Massachusetts Institute of Technology and an MD from Dartmouth Medical School.

Basic Compensation

Total Annual Compensation, USD 435,000
Restricted Stock Awards, USD 209,775
Long-Term Incentive Plans, USD --
All Other, USD 921,817
Fiscal Year Total, USD 1,566,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 68,961 1,944,280.00
Name Fiscal Year Total

Francois Nader


Habib Dable


Kevin McLaughlin


Steven Ertel


Matthew Sherman


Ravindra Kumar

As Of  30 Dec 2016